Otc Drugs Market Size, Share, Trends and Forecast 2016

OTC Drugs Market Share and Size, Pipeline Analysis, Commercial Trends, Operational Strategies Research Report By Radiant Insights Inc.

GBI Research’s latest report, ""The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects"" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current market drivers and restraints, mergers and acquisitions (M&A) activity and recent regulatory developments in key national markets. Furthermore, this report analyses leading therapeutic segments in the OTC drugs market, key brands, manufacturers and the potential for new product categories to be created as more prescription-only drugs from diverse therapy areas continue to be considered for OTC approval.

The OTC drugs market remains highly competitive and fragmented albeit leading companies continue to consolidate their market position through high-profile and strategic acquisitions. GBI Research expects M&A to remain very active in the coming years fueled by strategic long-term commercial priorities, as companies look to increase revenues through expanded OTC portfolios.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/the-otc-drugs-market-commercial-trends-and-rx-to-otc-switch-prospects

Key Reasons to Purchase

This report will allow you to -

Gain insights into the OTC drugs market and future prospects for Rx-to-OTC switches: This report comprehensively describes and assesses the commercial, regulatory and competitive landscape in this highly dynamic and lucrative industry.

Understand differing regulatory frameworks for OTC drugs and Rx-to-OTC switches in key markets: This report provides insights about established regulatory processes, approval frameworks and recent developments in the US, Europe, Japan, India and China for OTC drugs.

Table Of Content

Introduction

Key Global Trends in the OTC Drugs...